Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan 28;20(4):1005-20.
doi: 10.3748/wjg.v20.i4.1005.

Neuroanatomy of lower gastrointestinal pain disorders

Affiliations
Review

Neuroanatomy of lower gastrointestinal pain disorders

Wim Vermeulen et al. World J Gastroenterol. .

Abstract

Chronic abdominal pain accompanying intestinal inflammation emerges from the hyperresponsiveness of neuronal, immune and endocrine signaling pathways within the intestines, the peripheral and the central nervous system. In this article we review how the sensory nerve information from the healthy and the hypersensitive bowel is encoded and conveyed to the brain. The gut milieu is continuously monitored by intrinsic enteric afferents, and an extrinsic nervous network comprising vagal, pelvic and splanchnic afferents. The extrinsic afferents convey gut stimuli to second order neurons within the superficial spinal cord layers. These neurons cross the white commissure and ascend in the anterolateral quadrant and in the ipsilateral dorsal column of the dorsal horn to higher brain centers, mostly subserving regulatory functions. Within the supraspinal regions and the brainstem, pathways descend to modulate the sensory input. Because of this multiple level control, only a small proportion of gut signals actually reaches the level of consciousness to induce sensation or pain. In inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) patients, however, long-term neuroplastic changes have occurred in the brain-gut axis which results in chronic abdominal pain. This sensitization may be driven on the one hand by peripheral mechanisms within the intestinal wall which encompasses an interplay between immunocytes, enterochromaffin cells, resident macrophages, neurons and smooth muscles. On the other hand, neuronal synaptic changes along with increased neurotransmitter release in the spinal cord and brain leads to a state of central wind-up. Also life factors such as but not limited to inflammation and stress contribute to hypersensitivity. All together, the degree to which each of these mechanisms contribute to hypersensitivity in IBD and IBS might be disease- and even patient-dependent. Mapping of sensitization throughout animal and human studies may significantly improve our understanding of sensitization in IBD and IBS. On the long run, this knowledge can be put forward in potential therapeutic targets for abdominal pain in these conditions.

Keywords: Afferent nerves; Chronic pain; Inflammatory bowel disease; Irritable bowel syndrome; Sensitisation; Sensory nerves; Visceral hypersensitivity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cross section of the spinal cord. The central branches of the visceral afferents innervating the lower gastrointestinal tract travel via the dorsal root ganglia (DRG) and project onto the second order neurons in laminae I, II, V, X of the spinal gray matter. Ascending pathways arise in the anterolateral quadrant (ALQ; purple zone) and the dorsal column (DC; green zone) region in the spinal cord and project to higher brain centers (, medulla, thalamus).
Figure 2
Figure 2
Scheme is oversimplified and limited to the cell types and mediators discussed in this review and represents a subset of cells and inflammatory mediators responsible for activation of gut sensory afferents after an initial inflammatory response. 5-HT: 5-hydroxytryptamine; BK: Bradykinin; CGRP: Calcitonin-gene-related peptide; ECC: Enterochromaffin cell; GABA: Gamma-amino butyric acid; NGF: Nerve growth factor; NO: Nitric oxide; PAR: Proteinase-activated receptor; PG: Prostaglandin; SP: Substance P; TrKA: Tyrosine receptor kinase A; TRPA1: Transient receptor potential ankyrin-1; TRPV1: Transient receptor potential vanilloid-1; P2X3: Purinergic P2X3 receptor.

Similar articles

Cited by

References

    1. Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Crohn’s disease in the elderly: a comparison with young adults. J Clin Gastroenterol. 1998;27:129–133. - PubMed
    1. Chang L, Munakata J, Mayer EA, Schmulson MJ, Johnson TD, Bernstein CN, Saba L, Naliboff B, Anton PA, Matin K. Perceptual responses in patients with inflammatory and functional bowel disease. Gut. 2000;47:497–505. - PMC - PubMed
    1. Geboes K, Collins S. Structural abnormalities of the nervous system in Crohn’s disease and ulcerative colitis. Neurogastroenterol Motil. 1998;10:189–202. - PubMed
    1. De Schepper HU, De Man JG, Moreels TG, Pelckmans PA, De Winter BY. Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms. Aliment Pharmacol Ther. 2008;27:621–637. - PubMed
    1. Cross RK, Wilson KT, Binion DG. Narcotic use in patients with Crohn’s disease. Am J Gastroenterol. 2005;100:2225–2229. - PubMed

MeSH terms